Cargando…

IQCA-TAVV: To explore the effect of P-selectin, GPIIb/IIIa, IL-2, IL-6 and IL-8 on deep venous thrombosis

Deep vein thrombosis (DVT) associates with considerable morbidity, functional disability and mortality. Due to the lack of suitable inhibitor the correlation of various factors in DVT onset remains unknown. In this context we analyzed the structure of anti-platelet aggregation agent, P-selectin down...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jianhui, Zhu, Haimei, Yang, Guodong, Wang, Yuji, Wang, Yaonan, Zhao, Shurui, Zhao, Ming, Peng, Shiqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710932/ https://www.ncbi.nlm.nih.gov/pubmed/29207652 http://dx.doi.org/10.18632/oncotarget.20588

Ejemplares similares

Design and synthesis of nanoscaled IQCA-TAVV as a delivery system capable of antiplatelet activation, targeting arterial thrombus and releasing IQCA
por: Wu, Jianhui, et al.
Publicado: (2018)

Design and development of ICCA as a dual inhibitor of GPIIb/IIIa and P-selectin receptors
por: Chen, Haiyan, et al.
Publicado: (2018)

Discovery of DEBIC to correlate P-selectin inhibition and DNA intercalation in cancer therapy and complicated thrombosis
por: Chen, Haiyan, et al.
Publicado: (2017)

Lack of influence of the COX inhibitors metamizol and diclofenac on platelet GPIIb/IIIa and P-selectin expression in vitro
por: Scheinichen, Dirk, et al.
Publicado: (2004)

The GPIIb-IIIa defect of platelets in Glanzmann thrombasthenia
por: Nurden, Alan T.
Publicado: (2023)

Biosynthesis and processing of platelet GPIIb-IIIa in human megakaryocytes
Publicado: (1987)

N-(3-hydroxymethyl-β-carboline-1-yl-ethyl- 2-yl)-l-Phe: development toward a nanoscaled antitumor drug capable of treating complicated thrombosis and inflammation
por: Wu, Jianhui, et al.
Publicado: (2017)

Docking of THPDTPI: to explore P-selectin as a common target of anti-tumor, anti-thrombotic and anti-inflammatory agent
por: Zhu, Haimei, et al.
Publicado: (2017)

Aqueous extract of Rabdosia rubescens leaves: forming nanoparticles, targeting P-selectin, and inhibiting thrombosis
por: Wang, Yuji, et al.
Publicado: (2015)

Thrombin promotes platelet-mediated melanoma cell adhesion to endothelial cells under flow conditions: role of platelet glycoproteins P-selectin and GPIIb-IIIA.
por: Dardik, R., et al.
Publicado: (1998)

Platelet activation by C1q results in the induction of alpha IIb/beta 3 integrins (GPIIb-IIIa) and the expression of P-selectin and procoagulant activity
Publicado: (1993)

Deep Vein Thrombosis Is Facilitated by Endothelial-Derived Extracellular Vesicles via the PDI–GRP94–GPIIb/IIIa Pathway in Mice
por: Lan, Hongtao, et al.
Publicado: (2023)

Elevating local concentrations of GPIIb–IIIa antagonists counteracts platelet thrombus stability
por: Speich, Henry E., et al.
Publicado: (2012)

Construction and expression of D-dimer and GPIIb/IIIa single-chain bispecific antibody
por: DAN, ZHAOKUI, et al.
Publicado: (2013)

Modifying tetramethyl–nitrophenyl–imidazoline with amino acids: design, synthesis, and 3D-QSAR for improving inflammatory pain therapy
por: Jiang, Xueyun, et al.
Publicado: (2015)

Correlation between the expression of IL-18 and deep venous thrombosis
por: Li, Guangdi, et al.
Publicado: (2018)

Development of 13-Cys-BBR as an Agent Having Dual Action of Anti-Thrombosis and Anti-Inflammation
por: Li, Guanyu, et al.
Publicado: (2020)

Nanoparticles of a New Small-Molecule P-Selectin Inhibitor Attenuate Thrombosis, Inflammation, and Tumor Growth in Two Animal Models
por: Feng, Qiqi, et al.
Publicado: (2021)

Cu(2+)-RGDFRGDS: exploring the mechanism and high efficacy of the nanoparticle in antithrombotic therapy
por: Wu, Jianhui, et al.
Publicado: (2015)

Decreased Platelet Specific Receptor Expression of P-Selectin and GPIIb/IIIa Predict Future Non-Surgical Bleeding in Patients after Left Ventricular Assist Device Implantation
por: Klaeske, Kristin, et al.
Publicado: (2022)

ATIQCTPC: a nanomedicine capable of targeting tumor and blocking thrombosis in vivo
por: Xu, Xinyi, et al.
Publicado: (2017)

Admission Levels of Serum P-Selectin and IL-6 Can Predict Development of Deep Venous Thrombosis in Hospitalized Covid-19 Patients
por: Farouk, Nehal, et al.
Publicado: (2022)

Evidence for the selective association of a subpopulation of GPIIb-IIIa with the actin cytoskeletons of thrombin-activated platelets
Publicado: (1993)

Functional Comparison of Induced Pluripotent Stem Cell- and Blood-Derived GPIIbIIIa Deficient Platelets
por: Orban, Mathias, et al.
Publicado: (2015)

Eptifibatide and Cirrhosis: Rethinking GPIIb-IIIa Inhibitors for Acute Coronary Syndrome in the Setting of Liver Dysfunction
por: Weinreich, Michael, et al.
Publicado: (2014)

Correlation between the expression of IL-18 and deep venous thrombosis
Publicado: (2018)

Small molecule PZL318: forming fluorescent nanoparticles capable of tracing their interactions with cancer cells and activated platelets, slowing tumor growth and inhibiting thrombosis
por: Li, Shan, et al.
Publicado: (2015)

Platelets Induce Apoptosis during Sepsis in a Contact-Dependent Manner That Is Inhibited by GPIIb/IIIa Blockade
por: Sharron, Matthew, et al.
Publicado: (2012)

Safety of bridging antiplatelet therapy with the gpIIb-IIIa inhibitor tirofiban after emergency stenting in stroke
por: Lee, John-Ih, et al.
Publicado: (2017)

Nano-scaled MTCA-KKV: for targeting thrombus, releasing pharmacophores, inhibiting thrombosis and dissolving blood clots in vivo
por: Zhao, Shurui, et al.
Publicado: (2019)

Case report: Early thrombosis in left atrial during transcatheter closure of ASD in a child with favorable outcome after use of GPIIb/IIIa receptor antagonist and heparin
por: Wang, Hui, et al.
Publicado: (2023)

RGD-independent binding of Russell’s Viper venom Kunitz-type protease inhibitors to platelet GPIIb/IIIa receptor
por: Kalita, Bhargab, et al.
Publicado: (2019)

Uncoupling of platelet granule release and integrin activation suggests GPIIb/IIIa as a therapeutic target in COVID-19
por: Weiss, Lukas J., et al.
Publicado: (2022)

Comparison of the effects of the GPIIb-IIIa antagonist Zalunfiban and the P2Y12 antagonist Selatogrel on Platelet Aggregation
por: Curry, Benjamin J., et al.
Publicado: (2023)

P‐ and E‐ selectin in venous thrombosis and non‐venous pathologies
por: Purdy, Megan, et al.
Publicado: (2022)

Novel Thrombolytic Drug Based on Thrombin Cleavable Microplasminogen Coupled to a Single‐Chain Antibody Specific for Activated GPIIb/IIIa
por: Bonnard, Thomas, et al.
Publicado: (2017)

miR-204-5p and Platelet Function Regulation: Insight into a Mechanism Mediated by CDC42 and GPIIbIIIa
por: Garcia, Alix, et al.
Publicado: (2021)

RGD(F/S/V)-Dex: towards the development of novel, effective, and safe glucocorticoids
por: Jiang, Xueyun, et al.
Publicado: (2016)

Platelet Activation in Ovarian Cancer Ascites: Assessment of GPIIb/IIIa and PF4 in Small Extracellular Vesicles by Nano-Flow Cytometry Analysis
por: Bortot, Barbara, et al.
Publicado: (2022)

Exploring the action of RGDV-gemcitabine on tumor metastasis, tumor growth and possible action pathway
por: Zhang, Xiaoyi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pded9urrdss79hh6e3vk6sv5ge